Lucid Diagnostics Q2 Adj. EPS $(0.08) Misses $(0.07) Estimate, Sales $1.474M Miss $1.943M Estimate
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by 33.33 percent. This is a 20 percent increase over losses of $(0.10) per share from
